125 related articles for article (PubMed ID: 29755100)
1. [Induction Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer].
Miura A; Soh J; Shien K; Yamamoto H; Toyooka S
Kyobu Geka; 2018 Apr; 71(4):270-277. PubMed ID: 29755100
[TBL] [Abstract][Full Text] [Related]
2. [Outcome of Surgical Treatment of Locally Advanced Lung Cancer after Induction Chemoradiotherapy].
Tanahashi M; Yukiue H; Suzuki E; Yoshii N; Kitazawa S; Kaminuma Y; Niwa H
Kyobu Geka; 2018 Apr; 71(4):278-283. PubMed ID: 29755101
[TBL] [Abstract][Full Text] [Related]
3. [Induction Chemoradiotherapy Followed by Surgery in Non-small-cell Lung Cancer;a Retrospective Study].
Yamanashi K; Okumura N; Takahashi A; Nakashima T; Matsuoka T; Yokoyama T; Itasaka S
Kyobu Geka; 2018 Aug; 71(8):563-572. PubMed ID: 30185752
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
[TBL] [Abstract][Full Text] [Related]
5. [When Should We Perform Surgery for N2 Lung Cancer?;Induction Chemoradiotherapy or Surgery for Local Recurrence or Residual Tumor after Definitive Chemoradiotherapy].
Ito H; Nakayama H
Kyobu Geka; 2018 Apr; 71(4):290-299. PubMed ID: 29755103
[TBL] [Abstract][Full Text] [Related]
6. Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
Yamaguchi M; Shimamatsu S; Edagawa M; Hirai F; Toyozawa R; Nosaki K; Seto T; Takenoyama M; Ichinose Y
Surg Today; 2019 Mar; 49(3):197-205. PubMed ID: 30610361
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of
Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
[TBL] [Abstract][Full Text] [Related]
8. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
Gielda BT; Mehta P; Khan A; Marsh JC; Zusag TW; Warren WH; Fidler MJ; Abrams RA; Bonomi P; Liptay M; Faber LP
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):985-91. PubMed ID: 20932684
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery.
Ahn HK; Choi YL; Han JH; Ahn YC; Kim K; Kim J; Shim YM; Um SW; Kim H; Kwon OJ; Sun JM; Ahn JS; Park K; Ahn MJ
Lung Cancer; 2013 Mar; 79(3):300-6. PubMed ID: 23261144
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nutrition index affects the prognosis of patients undergoing trimodality therapy for locally advanced non-small cell lung cancer.
Soh J; Suzawa K; Shien K; Otani S; Yamamoto H; Okazaki M; Sugimoto S; Katsui K; Yamane M; Kiura K; Kanazawa S; Toyooka S
Surg Today; 2020 Dec; 50(12):1610-1618. PubMed ID: 32914233
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
[TBL] [Abstract][Full Text] [Related]
12. Role of surgery in N2 NSCLC: pros.
Shien K; Toyooka S
Jpn J Clin Oncol; 2016 Dec; 46(12):1168-1173. PubMed ID: 27655902
[TBL] [Abstract][Full Text] [Related]
13. [Expectation for Surgery in Multi-modality Treatment in Non-small Cell Lung Cancer].
Sugio K
Kyobu Geka; 2018 Apr; 71(4):249-255. PubMed ID: 29755097
[TBL] [Abstract][Full Text] [Related]
14. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
15. [Review of chemoradiotherapy followed by surgical resection in locally advanced non-small-cell lung cancer].
Futamura Y; Sawa T; Hasegawa T; Horiba A; Ishiguro T; Yoshida T; Kinoshita T; Marui T; Murakami E; Azuma K; Murakawa S; Iida T
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2390-2. PubMed ID: 23268087
[TBL] [Abstract][Full Text] [Related]
16. Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?
Sato H; Soh J; Hotta K; Katsui K; Kanazawa S; Kiura K; Toyooka S
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):131-138. PubMed ID: 29681596
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.
Mitsuyoshi T; Matsuo Y; Itou H; Shintani T; Iizuka Y; Kim YH; Mizowaki T
J Radiat Res; 2018 Jan; 59(1):50-57. PubMed ID: 29182777
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
Nakamichi S; Horinouchi H; Asao T; Goto Y; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Ito Y; Watanabe SI; Ohe Y
Clin Lung Cancer; 2017 Nov; 18(6):e441-e448. PubMed ID: 28583380
[TBL] [Abstract][Full Text] [Related]
19. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
Speirs CK; DeWees TA; Rehman S; Molotievschi A; Velez MA; Mullen D; Fergus S; Trovo M; Bradley JD; Robinson CG
J Thorac Oncol; 2017 Feb; 12(2):293-301. PubMed ID: 27743888
[TBL] [Abstract][Full Text] [Related]
20. [Multimodality Therapy for Lung Cancer with Chest Wall Invasion].
Kawaguchi K; Yokoi K
Kyobu Geka; 2018 Apr; 71(4):285-289. PubMed ID: 29755102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
